MedPath

IMPRIMIS PHARMACEUTICALS, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety of Impracor (Ketoprofen 10% Cream) Compared With Placebo in the Treatment of Acute Pain (Flare) Associated With Osteoarthritis of the Knee

Phase 3
Withdrawn
Conditions
Acute Pain (Flare) Associated With Osteoarthritis (OA) of the Knee
Interventions
First Posted Date
2013-07-02
Last Posted Date
2013-11-13
Lead Sponsor
Imprimis Pharmaceuticals, Inc.
Registration Number
NCT01890902

Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury

Phase 3
Withdrawn
Conditions
Sprain
Interventions
First Posted Date
2010-10-18
Last Posted Date
2012-09-05
Lead Sponsor
Imprimis Pharmaceuticals, Inc.
Registration Number
NCT01223053

Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury

Phase 3
Completed
Conditions
Sprain
Strain
Acute Soft Tissue Injury
Interventions
Drug: Topical Placebo Cream
First Posted Date
2008-10-03
Last Posted Date
2013-09-27
Lead Sponsor
Imprimis Pharmaceuticals, Inc.
Target Recruit Count
364
Registration Number
NCT00765700
Locations
🇺🇸

CATO Research, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath